Glendon E. French III - 15 Jul 2021 Form 4 Insider Report for Pulmonx Corp (LUNG)

Role: President and CEO, Director
Signature: /s/ Lauren Cristina, Attorney-in-Fact for Glendon E. French
Issuer symbol: LUNG
Transactions as of: 15 Jul 2021
Net transactions value: -$997,281
Form type: 4
Filing time: 19 Jul 2021, 19:48:03 UTC
Previous filing: 21 Jun 2021
Next filing: 23 Aug 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LUNG	Common Stock	Options Exercise	$9,625	+4,375	+0.36%	$2.20^*	1,231,734	15 Jul 2021	Direct
transaction	LUNG	Common Stock	Sale	$50,285	-1,337	-0.11%	$37.61	1,230,397	15 Jul 2021	Direct	F1, F2
transaction	LUNG	Common Stock	Sale	$433,794	-11,163	-0.91%	$38.86	1,219,234	15 Jul 2021	Direct	F1, F3
transaction	LUNG	Common Stock	Sale	$484,125	-12,500	-1%	$38.73	1,206,734	15 Jul 2021	Direct	F1
transaction	LUNG	Common Stock	Sale	$3,490	-93	-0.36%	$37.53	25,478	15 Jul 2021	See footnote	F4, F5
transaction	LUNG	Common Stock	Sale	$3,820	-100	-0.39%	$38.20	25,378	15 Jul 2021	See footnote	F4, F5
transaction	LUNG	Common Stock	Sale	$31,392	-807	-3.2%	$38.90	24,571	15 Jul 2021	See footnote	F4, F5, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LUNG	Employee Stock Option (right to buy)	Options Exercise	$0	-4,375	-2.1%	$0.000000	201,249	15 Jul 2021	Common Stock	4,375	$2.20	Direct	F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2020.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.14 to $38.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F3	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.20 to $39.18, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F4	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Glendon E. French III Children's Irrevocable Trust on December 15, 2020.
F5	The shares are directly held by the Glendon E. French III Children's Irrevocable Trust dated 11-17-98 for which the Reporting Person is a trustee.
F6	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.75 to $39.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F7	The shares subject to the option are immediately exercisable and vest in 48 equal monthly installments beginning on August 28, 2020, subject to the Reporting Person's continuous service through each such vesting date.